While thats a good thing, you may find yourself eating too little or even skipping meals
The -glutamyl cycle: a possible transport system for amino acids

Risk factors that may influence the decision to pause treatment include: Being in the dose-escalation phase of GLP-1 therapy Experiencing active gastrointestinal symptoms (nausea, vomiting, bloating) Having known gastroparesis or other conditions affecting gastric emptying Taking concurrent medications that further delay gastric emptying (e.g., opioids) Undergoing procedures with higher aspiration risk (e.g., emergency surgery, airway surgery) If your anaesthetist or surgical team advises temporary cessation based on your individual risk assessment, the timing will depend on the specific medication: Daily injections (such as liraglutide): Typically paused 24 hours before surgery Weekly injections (such as semaglutide, dulaglutide): Often paused with the last dose given at least 7 days before surgery Oral semaglutide (Rybelsus): Usually paused 24 hours before surgery However, these timings may vary according to local NHS Trust protocols and individual clinical assessment

Applications include investigating stroke recovery mechanisms, neurodegenerative disease prevention, and ocular health optimization
Oily Skin: The T-zone (the forehead, nose and chin areas) has more sebaceous glands, thus, more susceptible to pimples
Uric acid is reduced in the substantia nigra in Parkinsons disease: effect on dopamine oxidation